Cloud-clone
SKU:RPC688Hu01
Recombinant Osteoglycin (OGN)
Recombinant Osteoglycin (OGN)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPC688Hu01
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Secreted, Extracellular matrix
Predicted Molecular Mass
14.9kDa
Accurate Molecular Mass
16/17kDa(Analysis of differences refer to the manual)
Residues & Tags
Leu180~Phe298 with N-terminal His Tag
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Traits
Freeze-dried powder
Purity
> 95%
Isoelectric Point
9.5
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Bone. | Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. pubmed:27836731 |
| Tohoku journal of experimental medicine | Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. pubmed:28824047 |
| Molecular Metabolism | Osteoglycin, a novel coordinator of bone and glucose homeostasis Pubmed:29799418 |
| Journal of Experimental & Clinical Cancer Research | Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway Pubmed:29499765 |
| Journal of Human Hypertension | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients Pubmed:29867136 |
| Cell Reports | Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue Pubmed: 30332637 |
| J Clin Endocrinol Metab | Osteoglycin across the adult lifespan 34850904 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPC688Hu01 | Recombinant Osteoglycin (OGN) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC688Hu01 | Polyclonal Antibody to Osteoglycin (OGN) | WB; IHC; ICC; IP. |
| LAC688Hu71 | Biotin-Linked Polyclonal Antibody to Osteoglycin (OGN) | WB; IHC; ICC. |
| MAC688Hu22 | Monoclonal Antibody to Osteoglycin (OGN) | WB; IHC; ICC; IP. |
| SEC688Hu | ELISA Kit for Osteoglycin (OGN) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC688Hu | Magnetic Luminex Assay Kit for Osteoglycin (OGN) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
